drugset / Trial / NCT00195767

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

NCT00195767

Phase 3 Completed 150 enrolled Abbott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine if long-term treatment, up to 6 months, with Depakote ER is safe and effective in the treatment of bipolar I disorder in children and adolescents.

Timeline

Start
2004-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule

Indications